BioCentury
ARTICLE | Company News

Cel-Sci other research news

February 5, 2001 8:00 AM UTC

CVM and the National Cancer Institute extended their CRADA to develop vaccines to treat mammary and prostate cancer using NCI's animal models and CVM's Ligand Epitope Antigen Presentation System ( L.E...